Search results will open in a new window on TMXMoney.com.

Exchange Bulletin

The Hydropothecary Corporation (HEXO, HEXO.WT) To Trade On Toronto Stock Exchange


June 20, 2018
Issuer: The Hydropothecary Corporation ("Hydropothecary")
Common Shares
Security: Common shares (the "Shares")
Symbol: HEXO
Number of securities issued and outstanding: 191,560,223 Shares
Number of securities reserved for issuance: 47,188,147 Shares
Trading currency: CDN$
Listing date: June 22, 2018 (at the opening)
Posted for trading date: June 22, 2018 (at the opening)
Warrants
Security: Share purchase warrants (the "Warrants")
Symbol: HEXO.WT
Exercise price: $5.60 per Share
Expiry: 5:00 p.m. (Eastern time) on January 30, 2020
Number of securities issued and outstanding: 18,577,500 Warrants
Number of securities reserved for issuance: Nil
Trading currency: CDN$
Listing date: June 22, 2018 (at the opening)
Posted for trading date: June 22, 2018 (at the opening)
Other Information
Listing category: Industrial, Non-Exempt Issuer
Other market(s): The Shares have been listed and trading on TSX Venture Exchange since March 21, 2017 under the symbol "THCX" and the Warrants under the symbol THCX.WT since February 2, 2018. The Shares and Warrants will be delisted from TSX Venture Exchange on June 22, 2018, upon commencement of trading on Toronto Stock Exchange. Upon listing on Toronto Stock Exchange, the Shares and Warrants will be traded under the new symbols "HEXO" and "HEXO.WT", respectively.
Temporary market maker: Citadel Securities Canada ULC
Security ownership registration: Shares: Certificated IssueWarrants: Uncertificated Issue – Non-Certificated Inventory
Investor relations: Ms. Jennifer Smith
(819) 742-0111, ext. 104
Email: jennifer.smith@thehydropothecary.com

Mr. Ed Chaplin
(613) 852-9372
Email: ed.chaplin@thehydropothecary.com
Incorporation: Business Corporations Act (Ontario)
Fiscal year end: July 31
Nature of business: Hydropothecary creates and distributes innovative, easy to use and easy to understand products under Health Canada's Access to Cannabis for Medical Purposes Regulations.
Transfer agent and registrar: TSX Trust Company at its principal offices in Toronto
Dividends: None anticipated in the foreseeable future
Sponsorship: Not applicable
Disclosure document: Annual Information Form dated November 8, 2017 which is available at www.SEDAR.com. Capitalized terms not otherwise defined herein are as defined in the disclosure document.
Additional information: Warrant indenture dated January 30, 2018 between Hydropothecary and TSX Trust Company
TSX contact: Julie K. Shin,
Director, Listed Issuer Services,
Toronto Stock Exchange